NYC Brain Computer Startup Announces FDA Trial Before Elon Musk
Publication Title
BloombergPublication/Creation Date
July 28 2021Creators/Contributors
Sarah McBride (creator)Synchron Inc. (contributor)
Thomas Oxley (contributor)
J Mocco (contributor)
Mount Sinai Hospital (contributor)
Food And Drug Administration (FDA) (contributor)
Elon Musk (contributor)
Media Type
Magazine ArticlePersuasive Intent
InformationDiscursive Type
Responses To InventionsDescription
"A brain-computer interface company is entering clinical trials for its implants in the U.S., a big step toward getting the futuristic devices into more skulls to help treat conditions like paralysis.New York-based Synchron Inc. said it received permission from the Food and Drug Administration to test its device in human patients. The trial, known as an early feasibility study, is essential to proving the implants work safely and could one day be sold in the U.S."
HCI Platform
ImplantablesRelation to Body
InSource
https://www.bloomberg.com/news/articles/2021-07-28/elon-musk-neuralink-competitor-announces-fda-trial-for-brain-deviceRelated Objects
Stentrode - Moving with the Power of ThoughtElon Musk’s Neuralink presentation
Stentrode brain computer interface online in first two human patients
Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis: first in-human experience
Related Items
Bloomberg L.P.Sarah McBride
Synchron Inc.
Thomas Oxley
J Mocco
Mount Sinai Hospital
Food And Drug Administration (FDA)
Elon Musk